Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Fresenius Claims Edge With US Tocilizumab Biosimilar Approval
German Firm’s Tyenne Rival To Actemra Wins FDA Nod In Both IV And SC Presentations
Mar 07 2024
•
By
Dave Wallace
Tyenne has been approved in both IV And SC formulations • Source: Shutterstock
More from Biosimilars
More from Products